Healthy Patients
Antimicrobial resistance (AMR)
AMR develops when bacteria, fungi or viruses are exposed to antibiotics, antifungals or antivirals. As a result, the antimicrobials become ineffective and infections may persist. In addition, medical interventions including surgery, chemotherapy and stem cell therapy may become impossible.
AMR is considered the biggest global threat of Health and Food Safety.
AMR Insights
For Healthcare professionals who wish to prevent Antimicrobial resistance, AMR Insights offers selected, global information and data, specific education and extensive networking and partnering opportunities.
AMR Insights is for:
- Medical Microbiologists, Infectiologists and other specialists
- General Practitioners, Pharmacists
- Infection Prevention Experts and nurses
- Medical Docters and Caretakers in nursing homes
- Managers and Labtechnicians of Microbiological Laboratories.
Latest Topics
-
11 March 2026Investigating the Effect of Hospital Infection Control Informatization on Optimizing Microbiological Specimen Submission Before Antibiotic Therapy: Failure Mode and Effects Analysis
This study examined how hospitals can improve microbiological testing before starting antibiotics, a key element of antimicrobial stewardship (AMS). Researchers used Failure Mode and Effects Analysis (FMEA) at a tertiary hospital in China to identify weaknesses in the specimen-submission workflow, including technology failures, limited clinical decision support, low clinician awareness, and patient-related barriers. Targeted digital […]
Read more... -
10 March 2026Successful systemic phage therapy for implant-associated MRSA spondylodiscitis
This article reports a clinical case demonstrating the successful use of systemic bacteriophage therapy to treat a chronic, antibiotic-refractory infection. A 60-year-old woman with methicillin-resistant Staphylococcus aureus (MRSA) vertebral osteomyelitis associated with non-removable spinal implants had failed multiple antibiotic regimens and developed hypersensitivity to most available drugs. Physicians administered individualized intravenous bacteriophage therapy (35 doses […]
Read more... -
02 March 2026Barriers to and facilitators of adherence to evidence-based standard antimicrobial treatment guidelines among physicians in Ethiopia: a formative qualitative study
The study used qualitative interviews with 47 physicians in 20 Ethiopian public hospitals to identify why adherence to evidence-based antimicrobial treatment guidelines is inconsistent; major barriers included bulky or outdated guidelines, limited training and confidence, resistance from senior clinicians, restricted access to medicines, delayed guideline dissemination, heavy workloads, and variable private-sector practices, while facilitators included […]
Read more...
More news related to Healthy patients
